| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 3.51e-04 | 507 | 69 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 3.51e-04 | 507 | 69 | 8 | GO:0030695 | |
| GeneOntologyBiologicalProcess | mitotic intra-S DNA damage checkpoint signaling | 2.36e-05 | 17 | 69 | 3 | GO:0031573 | |
| GeneOntologyBiologicalProcess | DNA replication checkpoint signaling | 3.92e-05 | 20 | 69 | 3 | GO:0000076 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 6.05e-05 | 23 | 69 | 3 | GO:0090161 | |
| GeneOntologyCellularComponent | checkpoint clamp complex | 1.04e-04 | 5 | 68 | 2 | GO:0030896 | |
| Domain | USP37-like_PH | 3.79e-05 | 3 | 67 | 2 | IPR032069 | |
| Domain | UCH_N | 3.79e-05 | 3 | 67 | 2 | PF16674 | |
| Domain | Spectrin_repeat | 1.51e-04 | 29 | 67 | 3 | IPR002017 | |
| Domain | CP2 | 1.88e-04 | 6 | 67 | 2 | PF04516 | |
| Domain | CP2 | 1.88e-04 | 6 | 67 | 2 | IPR007604 | |
| Domain | Spectrin/alpha-actinin | 2.03e-04 | 32 | 67 | 3 | IPR018159 | |
| Domain | SPEC | 2.03e-04 | 32 | 67 | 3 | SM00150 | |
| Domain | ConA-like_dom | 1.13e-03 | 219 | 67 | 5 | IPR013320 | |
| Domain | FH2 | 1.29e-03 | 15 | 67 | 2 | PS51444 | |
| Domain | FH2_Formin | 1.29e-03 | 15 | 67 | 2 | IPR015425 | |
| Domain | FH2 | 1.29e-03 | 15 | 67 | 2 | PF02181 | |
| Domain | FH2 | 1.29e-03 | 15 | 67 | 2 | SM00498 | |
| Domain | Spectrin | 3.06e-03 | 23 | 67 | 2 | PF00435 | |
| Domain | FIBRINOGEN_C_1 | 5.87e-03 | 32 | 67 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.87e-03 | 32 | 67 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 5.87e-03 | 32 | 67 | 2 | PS51406 | |
| Domain | - | 6.99e-03 | 35 | 67 | 2 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 7.38e-03 | 36 | 67 | 2 | IPR015422 | |
| Domain | ANF_lig-bd_rcpt | 7.79e-03 | 37 | 67 | 2 | IPR001828 | |
| Domain | ANF_receptor | 7.79e-03 | 37 | 67 | 2 | PF01094 | |
| Pubmed | Analysis of protein variations in adult and postnatal day 11 staggerer and lurcher mutant mice. | 3.88e-06 | 2 | 69 | 2 | 8513552 | |
| Pubmed | Discrimination learning in Rora(sg) and Grid2(ho) mutant mice. | 3.88e-06 | 2 | 69 | 2 | 18583162 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9813341 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 7478307 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11073954 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30981110 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 7673468 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17327361 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1804324 | ||
| Pubmed | Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation. | 3.88e-06 | 2 | 69 | 2 | 20661472 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18156970 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8509510 | ||
| Pubmed | TBC1D10B RANGAP1 KRT16 DSP SYNE2 PSD3 ZNF638 PSMC4 PTPRT CEP55 FAN1 | 6.57e-06 | 1049 | 69 | 11 | 27880917 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 8848495 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19464297 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 29410248 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11340080 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 10777662 | ||
| Pubmed | The Rad9 protein enhances survival and promotes DNA repair following exposure to ionizing radiation. | 1.16e-05 | 3 | 69 | 2 | 16814252 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 31291229 | ||
| Pubmed | Tri-cistronic cloning, overexpression and purification of human Rad9, Rad1, Hus1 protein complex. | 1.16e-05 | 3 | 69 | 2 | 17493829 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12228248 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 10871397 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 8833100 | ||
| Pubmed | Staggerer mutant mouse Purkinje cells do not contain detectable calmodulin mRNA. | 1.16e-05 | 3 | 69 | 2 | 2355223 | |
| Pubmed | Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins. | 1.16e-05 | 3 | 69 | 2 | 18794804 | |
| Pubmed | Association of the Rad9-Rad1-Hus1 checkpoint clamp with MYH DNA glycosylase and DNA. | 1.16e-05 | 3 | 69 | 2 | 26021743 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 36841485 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 9872989 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11994305 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 10852904 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 19615952 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 26088138 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 21978893 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 17488291 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 12578958 | ||
| Pubmed | The KYxxL motif in Rad17 protein is essential for the interaction with the 9-1-1 complex. | 2.32e-05 | 4 | 69 | 2 | 27387238 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 15314187 | ||
| Pubmed | Mechanism of stimulation of human DNA ligase I by the Rad9-rad1-Hus1 checkpoint complex. | 2.32e-05 | 4 | 69 | 2 | 16731526 | |
| Pubmed | The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1. | 2.32e-05 | 4 | 69 | 2 | 15556996 | |
| Pubmed | Identification and characterization of a paralog of human cell cycle checkpoint gene HUS1. | 2.32e-05 | 4 | 69 | 2 | 11944979 | |
| Pubmed | HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. | 2.32e-05 | 4 | 69 | 2 | 10846170 | |
| Pubmed | The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. | 2.32e-05 | 4 | 69 | 2 | 17395641 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11573955 | ||
| Pubmed | Dependence of parvalbumin expression on Purkinje cell input in the deep cerebellar nuclei. | 2.32e-05 | 4 | 69 | 2 | 9514513 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 15871698 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 31776186 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 10359610 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 2077109 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 17855402 | ||
| Pubmed | TopBP1 controls BLM protein level to maintain genome stability. | 2.63e-05 | 29 | 69 | 3 | 24239288 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 15897895 | ||
| Pubmed | Structure and functional implications of the human rad9-hus1-rad1 cell cycle checkpoint complex. | 3.86e-05 | 5 | 69 | 2 | 19535328 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 25911100 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 22586102 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 25602520 | ||
| Pubmed | PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition. | 3.86e-05 | 5 | 69 | 2 | 11077446 | |
| Pubmed | Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. | 3.86e-05 | 5 | 69 | 2 | 17583730 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 14500360 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 19523882 | ||
| Pubmed | The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9. | 3.86e-05 | 5 | 69 | 2 | 10884395 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 16216273 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.23e-05 | 332 | 69 | 6 | 32786267 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 32461361 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 8230318 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 14624239 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 12666198 | ||
| Pubmed | Interaction between human mismatch repair recognition proteins and checkpoint sensor Rad9-Rad1-Hus1. | 5.79e-05 | 6 | 69 | 2 | 20188637 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 26063178 | ||
| Pubmed | Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration. | 5.79e-05 | 6 | 69 | 2 | 25299344 | |
| Pubmed | A role for the phosphorylation of hRad9 in checkpoint signaling. | 5.79e-05 | 6 | 69 | 2 | 12734188 | |
| Pubmed | Identification and characterization of RAD9B, a paralog of the RAD9 checkpoint gene. | 5.79e-05 | 6 | 69 | 2 | 14611806 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 RANGAP1 WASHC4 PLEKHG4 DSP MDC1 ZBTB10 ZNF638 PSMC4 GEMIN5 MED12 | 6.81e-05 | 1353 | 69 | 11 | 29467282 |
| Pubmed | 7.94e-05 | 708 | 69 | 8 | 39231216 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 12628935 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11907025 | ||
| Pubmed | Behavioral effects of neonatal lesions on the cerebellar system. | 1.08e-04 | 8 | 69 | 2 | 25907855 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 23468651 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 32179579 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 20545769 | ||
| Pubmed | ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. | 1.08e-04 | 8 | 69 | 2 | 18162465 | |
| Pubmed | Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner. | 1.08e-04 | 8 | 69 | 2 | 33864866 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 2230805 | ||
| Pubmed | Spontaneous and induced mouse mutations with cerebellar dysfunctions: behavior and neurochemistry. | 1.38e-04 | 9 | 69 | 2 | 16499884 | |
| Pubmed | 1.49e-04 | 402 | 69 | 6 | 24722188 | ||
| Pubmed | Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration. | 1.73e-04 | 10 | 69 | 2 | 1565842 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 21050275 | ||
| Pubmed | 2.83e-04 | 453 | 69 | 6 | 29656893 | ||
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 21659603 | ||
| Pubmed | Differential gene expression in migrating cortical interneurons during mouse forebrain development. | 2.98e-04 | 13 | 69 | 2 | 20151419 | |
| Pubmed | Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression. | 2.98e-04 | 13 | 69 | 2 | 35913115 | |
| Pubmed | 3.10e-04 | 162 | 69 | 4 | 15174051 | ||
| Pubmed | 3.14e-04 | 653 | 69 | 7 | 22586326 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.27e-04 | 1105 | 69 | 9 | 35748872 | |
| Pubmed | Expression of multiple formins in adult tissues and during developmental stages of mouse brain. | 3.48e-04 | 14 | 69 | 2 | 26272686 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 33305180 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 27551807 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 19703589 | ||
| Pubmed | 4.43e-04 | 493 | 69 | 6 | 15368895 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 4.85e-04 | 925 | 69 | 8 | 28986522 | |
| Cytoband | 11q14.3 | 1.07e-03 | 32 | 69 | 2 | 11q14.3 | |
| GeneFamily | Checkpoint clamp complex | 1.43e-05 | 3 | 40 | 2 | 1339 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 5.47e-03 | 50 | 40 | 2 | 721 | |
| GeneFamily | Ubiquitin specific peptidases | 6.82e-03 | 56 | 40 | 2 | 366 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 186 | 69 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 186 | 69 | 5 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 197 | 69 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 197 | 69 | 5 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 199 | 69 | 5 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 199 | 69 | 5 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 4.14e-05 | 124 | 69 | 4 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-05 | 128 | 69 | 4 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 139 | 69 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.67e-05 | 150 | 69 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.13e-05 | 152 | 69 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 160 | 69 | 4 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 160 | 69 | 4 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 164 | 69 | 4 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 164 | 69 | 4 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 69 | 4 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 170 | 69 | 4 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.44e-04 | 171 | 69 | 4 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 171 | 69 | 4 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 171 | 69 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 174 | 69 | 4 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 174 | 69 | 4 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 174 | 69 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 175 | 69 | 4 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 179 | 69 | 4 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 179 | 69 | 4 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 179 | 69 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 181 | 69 | 4 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 181 | 69 | 4 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 181 | 69 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 184 | 69 | 4 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 184 | 69 | 4 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.98e-04 | 186 | 69 | 4 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.98e-04 | 186 | 69 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 187 | 69 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.02e-04 | 187 | 69 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 189 | 69 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.15e-04 | 190 | 69 | 4 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.24e-04 | 192 | 69 | 4 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.28e-04 | 193 | 69 | 4 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | facs-Lung-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 193 | 69 | 4 | db5e43e0b571737e7006365bdf0575340b8b900b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 195 | 69 | 4 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 2.42e-04 | 196 | 69 | 4 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 196 | 69 | 4 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 2.42e-04 | 196 | 69 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 2.42e-04 | 196 | 69 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | 8623972c7a70b3565b7a3a4afe93f1e012008201 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-04 | 197 | 69 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 197 | 69 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-04 | 197 | 69 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 197 | 69 | 4 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.52e-04 | 198 | 69 | 4 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-04 | 198 | 69 | 4 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-04 | 198 | 69 | 4 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-04 | 198 | 69 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-04 | 198 | 69 | 4 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 198 | 69 | 4 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.56e-04 | 199 | 69 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 199 | 69 | 4 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | suprabasal_cell|World / shred by cell class for turbinate | 2.56e-04 | 199 | 69 | 4 | bfab5380ef074d14f0b5ed10851ad5c898eb9a58 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 995d710d7302272e7951a5a5d766d1039089ee2b | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 2.56e-04 | 199 | 69 | 4 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 199 | 69 | 4 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | e9c47f565a0a7737ecff68569d668aeb707ae5a6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 199 | 69 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 199 | 69 | 4 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | fe22833e69928a1478df265e1c356c463611dedd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 199 | 69 | 4 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.56e-04 | 199 | 69 | 4 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 199 | 69 | 4 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.61e-04 | 200 | 69 | 4 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | 5f0f67958c9635db53e61f8370a92da6ea3e80fe | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.61e-04 | 200 | 69 | 4 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 2.61e-04 | 200 | 69 | 4 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-04 | 200 | 69 | 4 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 200 | 69 | 4 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.71e-06 | 195 | 67 | 7 | 2260_UP | |
| Drug | plakin | 4.34e-06 | 82 | 67 | 5 | CID000018752 | |
| Drug | desglucocheirotoxin | 8.53e-06 | 2 | 67 | 2 | CID000002862 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 1.25e-04 | 8 | 63 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | ceramide measurement | 1.48e-04 | 235 | 63 | 5 | EFO_0010222 | |
| Disease | testosterone measurement | STARD13 SYNE2 GADL1 CNTNAP2 PSD3 ZBTB10 RORA PLEKHM3 MED12 GALNT13 | 3.47e-04 | 1275 | 63 | 10 | EFO_0004908 |
| Disease | major depressive disorder (is_implicated_in) | 5.98e-04 | 17 | 63 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | diet measurement, body mass index | 8.32e-04 | 20 | 63 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | mean platelet volume | 1.43e-03 | 1020 | 63 | 8 | EFO_0004584 | |
| Disease | revision of total joint arthroplasty | 1.64e-03 | 28 | 63 | 2 | EFO_0020974 | |
| Disease | reticulocyte count | 1.66e-03 | 1045 | 63 | 8 | EFO_0007986 | |
| Disease | Major Depressive Disorder | 1.83e-03 | 243 | 63 | 4 | C1269683 | |
| Disease | intellectual disability (is_implicated_in) | 1.88e-03 | 30 | 63 | 2 | DOID:1059 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AENEECGQPMDDIQV | 1381 | Q9Y6Y1 | |
| FADACGLMNNNIEEQ | 501 | O00429 | |
| NNMGEQVTFDECGDL | 471 | P41180 | |
| LLEQQMQACTLDFEN | 351 | Q53EZ4 | |
| LQLENGQAMECTVAQ | 286 | Q9HCK5 | |
| GLENQEALQLQVACM | 316 | O60879 | |
| MFDENGEQYLDCINN | 41 | Q8TBG4 | |
| AQTAEIFQALQQECM | 701 | Q07912 | |
| EGCEQLQEVLEGFNM | 336 | P46060 | |
| EMCLGEEDFQQLQAQ | 196 | Q99638 | |
| IQRDGELCQQMEDFL | 391 | Q9C0D6 | |
| ELCQQMEDFLQFAIE | 396 | Q9C0D6 | |
| ELFQQMNDLEACVIQ | 111 | P01570 | |
| CFLENQGLEAVQSME | 701 | Q14676 | |
| RQMLQELVNAGCDQE | 101 | Q9NRM7 | |
| DNEAMQQDCVFENEE | 376 | Q9NYF5 | |
| EDGEFTECNNMTLIN | 351 | Q9H3H5 | |
| FQAVQEACELMNQGI | 76 | O43424 | |
| NLNDNQPMFEEVNCT | 556 | Q9NYQ8 | |
| CEMEQQSQEYQILLD | 391 | P08779 | |
| CLILNQDQMAQVFEG | 936 | Q93074 | |
| CQEENEDMVPDALQQ | 96 | Q3KNT7 | |
| NVDVCLAVQMDNLDG | 406 | Q6ZWE6 | |
| CFEDNLLMGEQLGNV | 91 | P58499 | |
| CEAPDANQQLQQAME | 356 | Q08379 | |
| LEDAFCEMNGALVQQ | 76 | A6NF36 | |
| CEMNGALVQQEEQAA | 81 | A6NF36 | |
| EFFIQNDQCQEMDTT | 216 | A8MWY0 | |
| LDMAENEGVVDIFNC | 1101 | O14522 | |
| GEIRNVETNQCLDNM | 431 | Q8IUC8 | |
| ENGLLDQAEMDCIVN | 191 | P49619 | |
| CLEINNFLDDGNQML | 36 | Q8NCM8 | |
| FNNLNGEDQDILMEN | 56 | P08700 | |
| AVMQDNPDCLVQAQA | 1031 | Q86XA9 | |
| QQLDLANCLDMQDFA | 131 | Q9UJP4 | |
| ELDECFAQANDQMEI | 106 | P15924 | |
| MFEIQGLKEQCENLQ | 456 | Q8IWJ2 | |
| IMAGEQVFQDCAEIQ | 281 | Q9Y264 | |
| ENEENIQCGENFMDI | 91 | P21554 | |
| SFQGCMQLIQVDDQL | 516 | Q9UHC6 | |
| DRQCPVDGDIDQQEM | 6 | Q6ZQY3 | |
| RQQECGIAVLEQMEN | 156 | Q9BQ95 | |
| DEMCANNDFVQVDPG | 61 | Q9Y2M0 | |
| NQVQDCQGFLMDLCE | 196 | Q8N1F8 | |
| CFLNDVVNLVEENQM | 791 | Q9Y3M8 | |
| ELLNQMDGFDQNVNV | 291 | P43686 | |
| ADMQQVLEQQLVGCQ | 4266 | Q8WXH0 | |
| NDLLAMDAIQGCDVN | 906 | Q58EX7 | |
| CELEQENFFNEFQME | 56 | O60921 | |
| QFMQEQGISLDEVDQ | 441 | Q9Y6H5 | |
| NAECMNQIEDNDDFQ | 341 | Q562F6 | |
| MNEEQYQKDGQLIEC | 501 | Q9NWF9 | |
| NEMVQNFQDESCFVL | 446 | Q9NZI6 | |
| QVDPCNLQELFQEMS | 251 | Q96NA8 | |
| SDEMIQNFQEEACFI | 471 | Q12800 | |
| IDGFMELCQNDQIVL | 341 | P35398 | |
| GCLAQEMQQQAQELL | 1476 | Q8TEQ6 | |
| GSQGMAEQLQQCIEE | 726 | Q9HBJ7 | |
| MAGIELERCQQQANE | 1 | O95183 | |
| EQLRNLPQQCMQEDF | 581 | Q4KMP7 | |
| LDQCLELQMFQGNCD | 1391 | P02549 | |
| LCEMLGNEQQQEDLE | 666 | Q86T82 | |
| LDGMIFQACIEQQFD | 256 | Q2M389 | |
| PLICQQFEADMNEQD | 131 | Q6UXN7 | |
| IDEDLRFQNCVMFNQ | 1011 | Q5TAH2 | |
| CNVDEGQIENYQMND | 521 | Q96DT7 | |
| MDSDDLQVFQNELIC | 1 | A6NGJ6 | |
| MDSDDLQVFQNELIC | 1 | A6NI03 | |
| MTCQEFIANLQGVNE | 701 | Q9NYI0 | |
| EECALNQQMFNSDLE | 1196 | Q14966 | |
| EQQEMECNEATFQLQ | 116 | Q9BXU2 |